The forecast for the R&D budget for Health and Society in the US from 2024 to 2028 remains static, consistently at 0.2% of GDP, indicating no year-on-year variation. This stability contrasts with previous years, likely reflecting budget constraints or strategic realignment. Although specific variations for 2022-2023 are required for precise analysis, the forecast suggests no expected growth over the next five years.

Future trends to watch for include:

Potential shifts in government focus and policy changes influencing R&D investment.
Emerging health challenges or technological advancements prompting budget adjustments.
Economic fluctuations that could impact overall GDP and, subsequently, R&D allocation.